✦ LIBER ✦

Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects

✍ Scribed by A. A. Holazo; W. A. Colburn; J. H. Gustafson; R. L. Young; M. Parsonnet

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 587 KB
Volume: 73
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600730821

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic profile of sulfisoxazole

Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man

✍ Stanley A. Kaplan; Robert E. Weinfeld; Charles W. Abruzzo; Margaret Lewis 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB

Pharmacokinetics of dolasetron following

Pharmacokinetics of dolasetron following single- and multiple-dose intravenous administration to normal male subjects

✍ Ajit Shah; Robert Lanman; Vijay Bhargava; Scott Weir; William Hahne 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Dolasetron, AnzemetTM, a 5-hydroxytryptamine receptor antagonist, is under investigation as an antiemetic agent. The keto-reduced metabolite of dolasetron has been identified in human plasma and is probably responsible for the majority of the antiemetic activity. This study evaluated the pharmacokin

Human dolasetron pharmacokinetics: I. Di

Human dolasetron pharmacokinetics: I. Disposition following single-dose intravenous administration to normal male subjects

✍ Harold Boxenbaum; Todd Gillespie; Kathleen Heck; William Hahne 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 2 views

Dolasetron is a 5-hydroxytryptamine antagonist active at type 111 receptors; it is presently undergoing clinical evaluation for the reduction/prevention of cancer chemotherapyinduced nausea and vomiting. Following intravenous administration to healthy male subjects of doses ranging from 0.6 to 5 mg

Pharmacokinetics of carbamazepine in mon

Pharmacokinetics of carbamazepine in monkeys following intravenous and oral administration

✍ R. H. Levy; J. S. Lockard; J. R. Green; P. Friel; L. Martis 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Pharmacokinetics of TDP223206 following

Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct-cannulated rats

✍ Yanmin Chen; Deping Cheng; Juan Jose Marugan; Carl Manthey; Bruce Tomczuk; Norma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 1 views

Differences in pharmacokinetics and ex v

Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats

✍ Chi-Sheng Shia; Yu-Chi Hou; Shang-Yuan Tsai; Pei-Hsun Huieh; Yann-Lii Leu; Pei-D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Emodin, a natural anthraquinone polyphenol, has been reported to possess promising in vitro antioxidation, anticancer and anti-inflammatory activities. Whether the in vitro bioactivities can predict in vivo effects remained an unanswered question without understanding emodin pharmacokinetics in anim